acivicin has been researched along with EHS Tumor in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, T; Burt, ME; Denton, JE; Faderan, MA; Lui, MS; Prajda, N; Reardon, MA; Sebolt, J; Weber, G; Zhen, YS | 1 |
| Alonso, MT; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Anderson, M; Burt, ME; Harrison, LE; Hochwald, SN; Rose, DM | 1 |
| Cao, L; Chance, WT; Fischer, JE; Zhang, FS | 1 |
| Cao, LQ; Chance, WT; Fischer, JE | 1 |
| Cao, L; Chance, WT; Fischer, JE; Foley-Nelson, T; Nelson, JL | 1 |
| Cao, L; Chance, WT; Fischer, JE | 1 |
| Cao, L; Chance, WT; Fischer, JE; Kim, MW; Nelson, JL | 1 |
8 other study(ies) available for acivicin and EHS Tumor
| Article | Year |
|---|---|
Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
Topics: Animals; Antimetabolites, Antineoplastic; Cells, Cultured; Dactinomycin; Deoxyribonucleotides; Glutamine; Humans; Isoxazoles; Liver Neoplasms, Experimental; Oxazoles; Rats; Rats, Inbred Strains; Ribonucleotides; Sarcoma, Experimental | 1982 |
Acivicin: a new glutamine antagonist in clinical trials.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glutamine; Half-Life; Humans; Isoxazoles; Kinetics; Leukemia, Experimental; Liver Neoplasms, Experimental; Macaca mulatta; Male; Mice; Neoplasms; Oxazoles; Purines; Pyrimidines; Sarcoma, Experimental | 1984 |
gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo.
Topics: Animals; Cysteine; Enzyme Inhibitors; Female; gamma-Glutamyltransferase; Glutathione; Isoxazoles; Methylcholanthrene; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1996 |
Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition.
Topics: Animals; Antibiotics, Antineoplastic; Clenbuterol; Drug Therapy, Combination; Intestine, Small; Isoxazoles; Lipid Metabolism; Liver; Male; Methylcholanthrene; Muscle Proteins; Muscles; Myocardium; Organ Size; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1991 |
Prolonged survival by tumor-bearing rats treated with acivicin and total parenteral nutrition.
Topics: Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; Isoxazoles; Male; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental; Survival Rate | 1990 |
Acivicin reduces tumor growth during total parenteral nutrition (TPN).
Topics: Animals; Antimetabolites; Body Weight; Glutamine; Isoxazoles; Male; Neoplasm Transplantation; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental; Soft Tissue Neoplasms | 1987 |
Insulin and acivicin improve host nutrition and prevent tumor growth during total parenteral nutrition.
Topics: Animals; Antimetabolites; Body Weight; Eating; Energy Intake; Insulin; Isoxazoles; Male; Muscle Proteins; Muscles; Organ Size; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1988 |
Reduction of tumor growth following treatment with a glutamine antimetabolite.
Topics: Amino Acids; Animals; Antibiotics, Antineoplastic; Antimetabolites; Body Weight; Energy Intake; Glutamine; Isoxazoles; Male; Methylcholanthrene; Oxazoles; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1988 |